Advanced Biomedical Technologies Inc. - FORM 10-K - EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - February 15, 2011

Attached files

file filename
EX-99.2 - DISCLOSURE COMMITTE CHARTER - Advanced Biomedical Technologies Inc.ex99_2.htm
EX-99.1 - AUDIT COMMITTEE CHARTER - Advanced Biomedical Technologies Inc.ex99_1.htm
EX-14.1 - CODE OF ETHICS - Advanced Biomedical Technologies Inc.ex-14_1.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Advanced Biomedical Technologies Inc.ex-31_1.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - Advanced Biomedical Technologies Inc.ex-31_2.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - Advanced Biomedical Technologies Inc.ex-32_2.htm
10-K - ANNUAL REPORT - Advanced Biomedical Technologies Inc.advancedbio-10k_103110.htm
 
Exhibit 32.1
 
 
CERTIFICATION PURSUANT TO
18 U.S.C. Section 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 
     In connection with the Annual Report of Advanced BioMedical Technologies Inc. (the "Company") on Form 10-K for the period ended October 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the "report"), I, Wang Hui, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)           The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and
 
(2)           The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
   
Dated this 15th day of February , 2011.
  
   
 
/s/ Wang Hui
  
Wang Hui, Director and Chief Executive Officer
  

Advanced Biomedical Technologies Inc. Reports